Analyst Upgrades

• Siemens (SI) to buy from hold at Deutsche Bank.
• Diamond Offshore (DO) to market perform from underperform at FBR Capital.
• MeadWestvaco (MWV) to conviction buy from neutral at Goldman.
• TD AmeriTrade (AMTD) and Cabot Oil & Gas (COG) to buy from neutral at BofA/Merrill.
• Janus Capital (JNS) to hold from sell at Citigroup.
• Motorola Mobility (MMI) to buy from neutral at UBS.
• Frontier Communications (FTR) to neutral from underperform at Macquarie.
• Humana (HUM) to buy from hold at Argus.

Continue reading Analyst Calls: AMTD, COG, DO, F, GM, HUM, LEA, MMI, NKE, SI, TRW ...

Analyst Calls: AMTD, COG, DO, F, GM, HUM, LEA, MMI, NKE, SI, TRW ... originally appeared on BloggingStocks on Fri, 18 Mar 2011 11:20:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• General Growth (GGP) to outperform from neutral at Credit Suisse.
• PPL Corp. (PPL) to outperform from market perform at FBR Capital.
• Hudson City Bancorp (HCBK) to neutral from reduce at Nomura.
• Hologic (HOLX) to conviction buy from buy at Goldman.
• Cognex (CGNX) to overweight from neutral at Piper Jaffray.
• Buckeye Partners (BPL) to outperform from market perform at Wells Fargo.
• Ericsson (ERIC) and Health Care REIT (HCN) to buy from neutral and Olin (OLN) to neutral from sell at UBS.
• Nalco (NLC) to overweight from neutral at JPMorgan.
• Watts Water (WTS) to buy from hold at BB&T.
• McDermott (MDR) to buy from neutral at Pritchard.

Continue reading Analyst Calls: AMTD, BPL, BX, ERIC, FTE, GGP, HCBK, HCN, NE, PPL, TUP ...

Analyst Calls: AMTD, BPL, BX, ERIC, FTE, GGP, HCBK, HCN, NE, PPL, TUP ... originally appeared on BloggingStocks on Thu, 03 Mar 2011 11:20:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• inContact (SAAS) to buy from neutral at Roth Capital.

Analyst Downgrades

• Ericsson (ERIC) to neutral from buy at Goldman.
• Hovnanian (HOV) to underperform from buy at BofA/Merrill.
• PrivateBancorp (PVTB) to market perform from outperform at BMO Capital.
• Logitech (LOGI) to neutral from outperform at Exane BNP Paribas.

Continue reading Analyst Calls: AGN, ERIC, HOV, LOGI, MMI, SAAS, SOL, TSLA ...

Analyst Calls: AGN, ERIC, HOV, LOGI, MMI, SAAS, SOL, TSLA ... originally appeared on BloggingStocks on Thu, 23 Dec 2010 11:20:00 EST. Please see our terms for use of feeds.

Continue reading Allergan's Botox Approved for Migraine Treatment

Allergan's Botox Approved for Migraine Treatment originally appeared on BloggingStocks on Mon, 18 Oct 2010 12:30:00 EST. Please see our terms for use of feeds.

As the opening bell sounded and stocks got off to a sluggish start, I decided to take a look for stocks that got off to a fast start. One of those stocks is Botox-maker Allergan (AGN). In early trading, the pharmaceutical firm was more than a percentage point higher, so I took to digging to find out why.

The biggest news I found for Allergan was that it entered into an Amended and Restated License, Development and Marketing Agreement with Inspire Pharmaceuticals. The agreement deals with terms related to the Prolacria 2% development program and Inspire's right to receive revenues from Allergan relating to net sales of Restasis and any other human opthalmic formulations of cyclosporine owned or controlled by Allergan. Simply put, Inspire will receive revenues on net sales of Restasis and any related cyclosporine-based medicines.

Continue reading Allergan Rallies on News of License Agreement

Allergan Rallies on News of License Agreement originally appeared on BloggingStocks on Wed, 25 Aug 2010 10:30:00 EST. Please see our terms for use of feeds.

Drug manufacturer Allergan, Inc. (AGN) will be reporting its second quarter results on Monday, with analysts expecting to see an 8% earnings increase from the same period last year.

Analysts have forecast earnings of $0.81 for the quarter, versus $0.75 during the same period last year.

Allergan has managed to outpace analyst estimates for each of the past six quarters, and has not failed to at least match estimates since the first quarter of 2007.

Continue reading Allergan Second Quarter Earnings Preview

Allergan Second Quarter Earnings Preview originally appeared on BloggingStocks on Fri, 30 Jul 2010 18:00:00 EST. Please see our terms for use of feeds.

If you're interested on taking a bet on a potential high-flyer, you might want to take a look at Allergan (AGN).

Goldman Sachs recently said they expect more M&A activity in pharmaceutical and that Allergan is a prime candidate for a takeover. Sanofi-Aventis (SNY) and Eli Lilly & Co. (LLY) are two companies analysts are speculating may be interested in acquiring Allergan.

Goldman also upgraded its price target for Allergan on its Conviction Buy List from $78 to $81.

Continue reading Goldman Sachs Targets Allergan as Takeover Candidate

Goldman Sachs Targets Allergan as Takeover Candidate originally appeared on BloggingStocks on Tue, 13 Jul 2010 13:30:00 EST. Please see our terms for use of feeds.

Continue reading Options Update: Alcoa Volatility Increases, Shares Near 11-Month Low

Options Update: Alcoa Volatility Increases, Shares Near 11-Month Low originally appeared on BloggingStocks on Fri, 02 Jul 2010 18:00:00 EST. Please see our terms for use of feeds.

It appears that U.S.-based drug makers and cigarette companies caught the attention of traders Tuesday -- at least, that's what they're searching for.

If you want to know what stocks traders are interested in right now at this very second, you need look no further than what's hot in Google.

Here's what's hot Friday:

Continue reading Allergan, BJ's Wholesale and Others Heating Up in Google

Allergan, BJ's Wholesale and Others Heating Up in Google originally appeared on BloggingStocks on Fri, 02 Jul 2010 16:30:00 EST. Please see our terms for use of feeds.

Continue reading Allergan Rises On FDA Botox Approval

Allergan Rises On FDA Botox Approval originally appeared on BloggingStocks on Wed, 10 Mar 2010 13:20:00 EST. Please see our terms for use of feeds.

Here are some highlights from last week's earnings coverage from BloggingStocks:

• Aetna Inc. (NYSE: AET) reported better-than-expected Q3 earnings and revenue, sending shares higher.
• Allergan Inc. (NYSE: AGN) reported better-than-expected Q3 numbers, sending shares higher.
• Bare Escentuals Inc. (NASDAQ: BARE) Q3 profit easily topped analysts' estimates, and shares surged.
• Cabot Oil & Gas Corp. (NYSE: COG) received an upgrade following the release of its Q3 numbers.
• Estee Lauder Companies Inc. (NYSE: EL) reported strong Q1 results, sending shares higher.
• E*Trade Financial Corp. (NASDAQ: ETFC) reported a smaller-than-expected net loss for Q3.
• Goodyear Tire & Rubber Co. (NYSE: GT) Q3 earnings topped estimates and revenue was up sequentially.

Continue reading Earnings highlights: Aetna, Allergan, E*Trade, Goodyear, RadioShack, SAP, Visa ...

Earnings highlights: Aetna, Allergan, E*Trade, Goodyear, RadioShack, SAP, Visa ... originally appeared on BloggingStocks on Sat, 31 Oct 2009 16:10:00 EST. Please see our terms for use of feeds.

As Jon Ogg reported, Allergan, Inc. (NYSE: AGN - option chain) rallied sharply on Tuesday amid rumors that GlaxoSmithKline (NYSE: GSK) was mulling a takeover bid. Speculative investors jumped all over the news, as option volume on AGN skyrocketed well beyond normal levels yesterday. Interestingly enough, it seems that some traders took advantage of the stock's surge to initiate new bearish positions.

Specifically, AGN on Tuesday saw 15,850 puts cross the tape, which represents about 14.5 times its average daily put trading volume. Meanwhile, 59,943 call contracts changed hands, marking 11.5 times the norm.

Continue reading Allergan, Inc. option volume surges on buyout speculation

Allergan, Inc. option volume surges on buyout speculation originally appeared on BloggingStocks on Wed, 25 Mar 2009 12:00:00 EST. Please see our terms for use of feeds.

Continue reading Closing Bell: Profit taking beats the bull (AGN, AIG, DOW, GS, LVS)

Closing Bell: Profit taking beats the bull (AGN, AIG, DOW, GS, LVS) originally appeared on BloggingStocks on Tue, 24 Mar 2009 16:00:00 EST. Please see our terms for use of feeds.

Merck (NYSE: MRK) is recently trading at $25.54 in pre-open trading, below its close of $26.46. MRK expects 2009 top-line growth will be offset by the effects of a volatile global economy. MRK December option implied volatility of 70 is above its 26-week average of 43 according to Track Data, suggesting larger price movement.

Allergan (NYSE: AGN) discovers and develops specialty pharmaceutical products. AGN closed at $36.20. AGN's Latisse (Bimatoprost for eyelash growth) PDUFA date is expected in mid-year 2009. AGN December option implied volatility is at 76, July is at 55; above its 26-week average of 50 according to Track Data, suggesting larger price movement.

Celgene (NASDAQ: CELG), a biopharmaceutical company, closed at $52.60. CELG's Revlimid's (non-Hodgkin's lymphoma treatment) incremental Phase 3 data on Revlimid in first line multiple myeloma is expected at the American Society of Hematology (ASH) meeting on December 6 to December 9. CELG December option implied volatility of 75 is above its 26-week average of 53 according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Options Update: Merck volatility elevated into lower 2009 outlook; AGN, CELG originally appeared on BloggingStocks on Thu, 04 Dec 2008 08:48:00 EST. Please see our terms for use of feeds.

Continue reading Cramer on BloggingStocks: Europe is starting to eye U.S. gems

Cramer on BloggingStocks: Europe is starting to eye U.S. gems originally appeared on BloggingStocks on Thu, 08 May 2008 09:00:00 EST. Please see our terms for use of feeds.

Trade idea for Allergan (AGN) downgrade originally appeared on BloggingStocks on Fri, 02 May 2008 13:52:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Dynamic Materials (NASDAQ: BOOM) was downgraded to Neutral from Overweight at J.P. Morgan following the Q1 report based on margin risk from steel costs and availability.
  
• Allergan (NYSE: AGN) was downgraded to Hold from Buy at Jefferies ahead of the Q1 report on May 7 based on potential deceleration in Botox and breast implants, which could result in multiple contractions.
• Sun Microsystems (NASDAQ: JAVA) was downgraded to Peer Perform from Outperform at Bear, citing the disappointing earnings report for the downgrade.

• ManTech (NASDAQ: MANT) was downgraded to Neutral from Outperform at Cowen based on valuation and expectations for decelerating growth in 2H08.
  
• Silver State Bancorp (NASDAQ: SSBX) was downgraded to Sell from Hold at Sandler O'Neil.

Analyst downgrades: BOOM, AGN and JAVA originally appeared on BloggingStocks on Fri, 02 May 2008 11:00:00 EST. Please see our terms for use of feeds.

Continue reading Allergan is part of the skin care revolution

Allergan is part of the skin care revolution originally appeared on BloggingStocks on Tue, 04 Mar 2008 18:39:00 EST. Please see our terms for use of feeds.

Beyond Cramer: Allergan originally appeared on BloggingStocks on Mon, 11 Jun 2007 12:21:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Banc of America downgraded shares of both Nike and Foot Locker to Neutral from Buy, as the firm believes industry pressures in the U.S. could more than offset the potential turn in Europe and benefit from the 2008 Olympics.
• Cowen downgraded shares of ADTRAN, Bookham and Tellabs to Neutral from Outperform.
• Goldman Sachs also downgraded shares of Tellabs, to Sell from Neutral, as the firm believes the stock fully discounts the expected sales and margin improvement.

• Allergan Inc (NYSE: AGN) was downgraded to Equal Weight from Overweight at Morgan Stanley citing limited upside.
• Friedman Billings removed The Cheesecake Factory Incorporated (NASDAQ: CAKE) from its Top Picks and maintained its Outperform rating.
• Lehman downgraded shares of The First American Corporation (NYSE: FAF) to Equal-Weight from Overweight on increasing risk to the company's title margin and regulatory concerns.
• Matrix USA downgraded shares of Lowe's Companies Inc (NYSE: LOW) to Buy from Strong Buy on valuation.

Analyst downgrades 6-08-07: NKE, FL, TLAB, ADTN and BKHM originally appeared on BloggingStocks on Fri, 08 Jun 2007 10:24:00 EST. Please see our terms for use of feeds.